Company

Abbisko's PIMJETMI (Pimicotinib) Wins FDA Approval for Symptomatic Tenosynovial Giant Cell Tumor – First U.S. Green Light for the China‑Born CSF‑1R Inhibitor
Abbisko TherapeuticsCancer

Abbisko’s PIMJETMI (Pimicotinib) Wins FDA Approval for Symptomatic Tenosynovial Giant Cell Tumor – First U.S. Green Light for the China‑Born CSF‑1R Inhibitor

Abbisko Therapeutics (HKG: 2256) announced that its independently developed small‑molecule colony‑stimulating factor 1 receptor (CSF‑1R) inhibitor, PIMJETMI (pimicotinib hydrochloride capsules), has received approval from the U.S. Food and Drug Administration…

Evopoint Biosciences' Imipenem/Cilastatin/Funobactam Wins NMPA Marketing Approval – Class 1 Triple‑Combination Antibiotic for HABP and VABP

Evopoint Biosciences’ Imipenem/Cilastatin/Funobactam Wins NMPA Marketing Approval – Class 1 Triple‑Combination Antibiotic for HABP and VABP

Eli Lilly's Foundayo (Orforglipron) Wins NMPA Approval – First Oral GLP‑1 Receptor Agonist for Adult Weight Management in China

Eli Lilly’s Foundayo (Orforglipron) Wins NMPA Approval – First Oral GLP‑1 Receptor Agonist for Adult Weight Management in China

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Pfizer's Ibrance Demonstrates Significant PFS Improvement in Phase III PATINA Trial
CancerClinical trial results

Pfizer’s Ibrance Demonstrates Significant PFS Improvement in Phase III PATINA Trial

BeiGene Ltd Acquires Global Rights to CSPC's MAT2A Inhibitor SYH2039
BeiGeneBeOne Medicines

BeiGene Ltd Acquires Global Rights to CSPC’s MAT2A Inhibitor SYH2039

Gan & Lee Pharmaceuticals Gets FDA Approval for GZR18 Obesity/Overweight Phase II Study
Clinical trial approval / initiationDiabetes

Gan & Lee Pharmaceuticals Gets FDA Approval for GZR18 Obesity/Overweight Phase II Study

HutchMed's Orpathys Receives Breakthrough Therapy Designation in China for Advanced Lung Cancer
AstraZenecaAZ

HutchMed’s Orpathys Receives Breakthrough Therapy Designation in China for Advanced Lung Cancer

Show More